[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100649744":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":34,"locations":40,"responsibleParty":62,"collaborators":25,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":25,"eligibilityCriteria":70,"healthyVolunteers":66,"sex":71,"minAge":72,"maxAge":25,"enrollmentInfo":73,"targetDuration":25,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":82,"overallStatus":91,"whyStopped":25,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"University Hospital, Basel, Switzerland","OTHER",[8,16],{"label":9,"type":10,"description":11,"interventionNames":12},"Deviskan","EXPERIMENTAL","Group Deviskan will be examined by Deviskan first followed by Vectra. Group Deviskan will receive questionnaire Version A, meaning questions referring to Deviskan are presented before those referring to Vectra.",[13,14,15],"Device: Deviskan","Device: Vectra WB360","Other: Standard-of-care clinical examinations",{"label":17,"type":10,"description":18,"interventionNames":19},"Vectra","Group Vectra will be examined by Vectra first followed by Deviskan. Group Vectra will receive questionnaire Version B, meaning questions referring to Vectra are presented before those referring to Deviskan.",[13,14,15],[21,26,30],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","Autonomous total body photography and dermoscopic imaging system Deviskan, Softwares: Devisoft, Devisual, Deviplatform, (Dermavision Solutions S. L., Figueres, Catalonia, Spain)",[9,17],null,{"type":22,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Vectra WB360","3D total body photography imaging system Vectra WB360, digital dermoscopic camera VISIOMED D200evo dermatoscope, DermaGraphix IntelliStudio, (Canfield Scientific Inc., Parsippany, New Jersey, USA)",[9,17],{"type":6,"name":31,"description":32,"armGroupLabels":33,"otherNames":25},"Standard-of-care clinical examinations","Active control with standard-of-care clinical examinations by experienced dermatologists.",[9,17],[35],{"name":36,"role":37,"phone":38,"phoneExt":25,"email":39},"Lea Habermacher","CONTACT","+41 61 328 60 48","lea.habermacher@usb.ch",[41],{"facility":42,"status":25,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"University Hospital Basel","Basel","Canton of Basel-City","4055","Switzerland","CH",{"type":49,"coordinates":50},"Point",[51,52],7.57327,47.55839,{"lat":52,"lon":51},[55,56,60],{"name":36,"role":37,"phone":38,"phoneExt":25,"email":39},{"name":57,"role":37,"phone":58,"phoneExt":25,"email":59},"Alexander Navarini, Prof. Dr. med. Dr. sc. nat.","+41 61 265 40 84","alexander.navarini@usb.ch",{"name":57,"role":61,"phone":25,"phoneExt":25,"email":25},"PRINCIPAL_INVESTIGATOR",{"type":63,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100649744","a-comparative-usability-study-of-two-total-body-skin-imaging-systems-100649744",false,"NCT07740642","A Comparative Usability Study of Two Total Body Skin Imaging Systems","A Comparative Usability Study of Two Total Body Skin Imaging Systems: Vectra (3D Total Body Photography With Manual Dermoscopy) Versus Deviskan (Total Body Photography With Automated Non-Contact Dermoscopy)","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Signed informed consent by the participant\n* Sufficient proficiency in German\n* At least one of the following risk criteria for melanoma:\n\n  * Previous melanoma (including in situ)\n  * Suspected melanoma\n  * ≥ 100 common naevi\n  * ≥ 5 dysplastic naevi\n  * dysplastic naevus syndrome\n  * Known CDKN2A mutation\n  * Strong family history for melanoma (≥ first- and\u002For second-degree relatives)\n\nExclusion Criteria:\n\n* Lack of informed consent\n* Immobility. (Patients must be able to stand without support for 30 minutes.)\n* Inability to follow the procedures of the investigation, including inability to follow on-screen instructions or to read (e.g. due to visual impairment or cognitive impairment)\n* Vulnerable Subjects\n* Active skin conditions that may impact the performance of TBP systems or skin cancer screenings\n* Cardiac pacemaker\n* Pregnant women (self reported, no pregnancy test planned)\n* Height below 150 cm or above 195 cm\n* Severe Claustrophobia","ALL","18 Years",{"count":74,"type":75},60,"ESTIMATED","INTERVENTIONAL",[78],"NA","This study aims to generate evidence on patient and dermatologist perspectives regarding two total body photography systems. Patient and clinician preferences represent key factors in healthcare decision-making. The investigation will also provide data on the time efficiency of each system in a real-world setting.",[81],"Melanoma (Skin Cancer)",[83,84,85,86,87,88,89,90],"Screening","Body Photography","Total Body Photography","Dermoscopic Imaging Device","dermoscopy","Body skin imaging","Dysplastic Naevi","CDKN2A Mutation","NOT_YET_RECRUITING","2026-07-31",{"date":94,"type":95},"2026-08-03","ACTUAL",{"date":94,"type":75},{"date":98,"type":75},"2026-09-30",{"name":5,"class":6},1]